Literature DB >> 18692939

Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays.

Gunes Coban1, Sevil Zencir, István Zupkó, Borbála Réthy, H Semih Gunes, Zeki Topcu.   

Abstract

Benzimidazoles are important compounds because of their antibacterial, antifungal, antimicrobial, antiprotozoal and antihelmintic activities. Some benzimidazole derivatives also interfere with the reactions of DNA topoisomerases, enzymes functioning at almost all stages of the cell cycle. In this study, nine 1H-benzimidazole derivatives with substituents at positions 2 and 5 were synthesized and the structure of the compounds was elucidated by instrumental methods. The characterized compounds were screened to identify if they interfered with mammalian type I DNA topoisomerase activity via in vitro supercoil relaxation assays. Selected compounds were subjected to cytostatic assays using HeLa (cervix adenocarcinoma), MCF7 (breast adenocarcinoma) and A431 (skin epidermoid carcinoma) cells. Our results showed that 5-chloro-2-(2-hydroxyphenyl)-1H-benzimidazole exerted the most profound topoisomerase I inhibition and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692939     DOI: 10.1016/j.ejmech.2008.06.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3.

Authors:  Chih-Hua Tseng; Cherng-Chyi Tzeng; Chiao-Li Yang; Pei-Jung Lu; Yu-Peng Liu; Hui-Ling Chen; Chien-Yu Chen; Chia-Ning Yang; Yeh-Long Chen
Journal:  Mol Divers       Date:  2013-11       Impact factor: 2.943

2.  Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives.

Authors:  Anuj Kumar; Somesh Banerjee; Partha Roy; S M Sondhi; Anuj Sharma
Journal:  Mol Divers       Date:  2017-11-15       Impact factor: 2.943

3.  Synthesis of amino ester-embedded benzimidazoles: a one-pot sequential protocol under metal-free neutral conditions.

Authors:  Priyabrata Roy; Chandan Bodhak; Animesh Pramanik
Journal:  Mol Divers       Date:  2016-09-27       Impact factor: 2.943

4.  Synthesis and biological activity of novel benzimidazole derivatives as potential antifungal agents.

Authors:  Weijie Si; Tao Zhang; Yaofa Li; Dongmei She; Wenliang Pan; Zhanlin Gao; Jun Ning; Xiangdong Mei
Journal:  J Pestic Sci       Date:  2016-02-20       Impact factor: 1.519

5.  In-silico docking based design and synthesis of [1H,3H] imidazo[4,5-b] pyridines as lumazine synthase inhibitors for their effective antimicrobial activity.

Authors:  Sunil L Harer; Manish S Bhatia
Journal:  J Pharm Bioallied Sci       Date:  2014-10

6.  Synthesis and Biological Evaluation of Novel 1H-Benzo[d]imidazole Derivatives as Potential Anticancer Agents Targeting Human Topoisomerase I.

Authors:  Stuti Pandey; Pragya Tripathi; Palak Parashar; Vikas Maurya; Md Zubbair Malik; Raja Singh; Pooja Yadav; Vibha Tandon
Journal:  ACS Omega       Date:  2022-01-10

7.  Conjugation of benzylvanillin and benzimidazole structure improves DNA binding with enhanced antileukemic properties.

Authors:  Zena A Al-Mudaris; Aman S A Majid; Dan Ji; Ban A Al-Mudarris; Shih-Hsun Chen; Po-Huang Liang; Hasnah Osman; Shah Kamal Khan Jamal Din; Amin M S Abdul Majid
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

8.  Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and evaluation for antibacterial/antifungal activity.

Authors:  Abdelaaziz Ouahrouch; Hana Ighachane; Moha Taourirte; Joachim W Engels; My Hassan Sedra; Hassan B Lazrek
Journal:  Arch Pharm (Weinheim)       Date:  2014-08-04       Impact factor: 3.751

9.  Skin Damages-Structure Activity Relationship of Benzimidazole Derivatives Bearing a 5-Membered Ring System.

Authors:  Ernestine Nicaise Djuidje; Elisa Durini; Sabrina Sciabica; Elena Serra; Jan Balzarini; Sandra Liekens; Stefano Manfredini; Silvia Vertuani; Anna Baldisserotto
Journal:  Molecules       Date:  2020-09-21       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.